Wednesday, July 8, 2026

biotech · Advanced Solid Tumor · Solid Tumor, Adult · IMMX

Immix Biopharma

Immix Biopharma trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Los Angeles, USA HQ
2012 Founded
39 Employees
Public company Type
IMMX · NYSE Ticker
Company details
Status
Public
HQ
Los Angeles, USA
Founded
2012
Employees
39
Programs
3
Drugs
2
Patents
2
Intelligence · Clinical Trials

Immix Biopharma clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Immix Biopharma programs — each row shows trial ID, program name, phase, status, and indication.

Immix Biopharma trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Immix Biopharma.

  1. NXC-201 CAR-T — Phase 2

    Clinical update
  2. IMX-110 combined with Tislelizumab — Phase 2

    Clinical update
  3. Imx-110 — Phase 2

    Clinical update

Trial registry

3 studies